Neogen names Avi Pelossof to board as William Boehm retires

Neogen Corporation (NASDAQ: NEOG) announced that William Boehm will retire from its board of directors effective October 23, 2025, after serving since 2011. Boehm currently chairs the Audit Committee and serves on the Compensation & Talent Management Committee.

The food safety solutions company will appoint Avi Pelossof to the board effective October 24, 2025. Pelossof brings over 25 years of diagnostics market experience, most recently serving as Chief Executive Officer, President, and board member at Immucor Inc., where he led the company's turnaround and its acquisition by Werfen in 2023.

Previously, Pelossof served as Global President, Infectious Disease at Alere Inc., where he built the business into a $750 million global portfolio and launched the first FDA CLIA-waived point-of-care molecular test, now marketed by Abbott as ID NOW.

"His track record of leading complex organizations through transformation, combined with his deep sector expertise, will bring valuable insight and perspective to our Board's work," said James C. Borel, Chair of the Neogen Board of Directors.

The information is based on a company press release statement.

You May Also Be Interested In

• Enerpac Tool Group to buy SFE Group for $472 million
• Lockheed Martin wins $607M in defense contracts
• Nasdaq to delist Platinum Analytics by July 16 unless appeal filed